|

Tuesdays with Turtles – Travel Edition

Byoliveridley

sm_mapping.jpgIt’s travel all the time for sea turtles. Of course, the great turtle race is finally on, and windy’s in the lead, my pick billie’s in second place, a mere 30 miles behind. There’s a new turtle in the race, Colbertia, named in honor of Stephen Colbert, in third place.

Anything that gets turtles some attention is good.

But this is only a 500 mile sprint. PBS’ nature series had a one hour documentary on an 8000 mile, one plus year journey of a loggerhead turtle from her juvenile feeding grounds in Mexico to her adult breeding ground in Japan. It’s great to spend an hour at that close proximity to a turtle. But to me, the other animals, the dolphin pods, the giant fish swarms, the hammerhead sharks, the other sharks, the jelly fish, those little fish that eat parasites off the turtles and sharks kinda stole the show. There is something about thousands of animals of the same species doing something in concert. 

Anyway, nothing more to say, except that 8000 miles is a long way at a mile an hour. I don’t think any of us can appreciate the mindfulness and sense of purpose (do turtles have these qualities, or do they just keep on chuggin’?), not to mention the huge amount of luck it takes to get it done.

Similar Posts

  • |

    Brazil successfully hardballs Abbott on AIDs drug

    Byoliveridley

    I mentioned in May that Brazil had introduced compulsory licensing on a Merck AIDs drug Efavirenz, and heartily recommended that Brazil and other third world countries continue to play hardball with big pharma whenever they could. It looks like Merck decided to not bargain, but Abbott did on Kaletra. Note that Abbott got into a similar controversy with Thailand, and agreed to drop the price when Thailand rejected the Kaletra patent.

    Keep it coming, third world countries. Bargaining is perfectly acceptable in the marketplace!

    Brazil says Abbott to cut price of AIDS drug | Health | Reuters

    razil’s health ministry said Wednesday that Abbott Laboratories Inc. agreed to cut the price of its Kaletra AIDS drug by 29.5 percent.

    The lower price for the drug, also known as lopinavir and ritonavir, will help Brazil supply free drugs for its AIDS treatment program.

    In May, President Luiz Inacio Lula da Silva authorized Brazil for the first time to break the patent on an AIDS drug, one made by Merck & Co.. It then started importing a generic version of the drug Efavirenz from India.

    Under WTO rules, countries can issue a “compulsory license” to manufacture or buy generic versions of patented drugs deemed critical to public health.

    Drug makers often reduce prices to keep countries as clients and avoid compulsory licenses.

  • Bonus Turtle Coverage – The Great Turtle Race

    Byoliveridley

    Great Turtle Race

    Follow eleven turtles as they sprint from Costa Rica to near the Galapagos. Each of them has a corporate sponsor, and at 20 miles an hour, they will get there in a couple of weeks! I think Billie’s going to win, but the leatherback turtle is in bad shape, endangered due to poaching, adult mortality and habitat loss. They may be gone very soon.

    Here’s the flickr page for the race, some beautiful pictures already.

  • |

    Bye Bye, Bisphenol A

    Byoliveridley

    Canada is expected to formally declare on Saturday that the controversial chemical bisphenol A (BPA) is a hazardous substance.

    The move will make Canada the first country in the world to put the chemical on a list of toxic substances that will ban the material from being used in such products as baby bottles.

    via CTV.ca | Canada to put BPA on toxic substances list

    Good for Canada. Timing of when cans (the biggest potential source of adult exposure) will be BPA free is up in the air.

  • | |

    The Pump handle and Diacetyl

    Byoliveridley

    The Pump Handle looks at the response of various government agencies (notionally charged with protecting American people) to increasing information about the danger of diacetyl exposure, certainly to workers in the flavoring industry, and recently, to consumers of microwave popcorn. An excellent post, deserves wider reading!


    Popcorn Lung Coming to Your Kitchen? The FDA Doesn’t Want to Know « The Pump Handle

    The CDC, FDA, OSHA, EPA – federal agencies charged with protecting public health – each received a letter in July alerting them to the possible serious respiratory hazard to consumers who breathe in fumes from their artificially butter-flavored microwave popcorn. The warning should have resulted in some action by these agencies, but instead, they’ve done virtually nothing.

    It appears that the Bush Administration’s efforts to destroy the regulatory system are succeeding; the agencies seem unable to mount a response to information that a well-functioning regulatory system would immediately pursue. The agencies aren’t even trying to connect the dots.

    Read on. I moved to the US in 1997 and I’ve noticed a stark difference in the performance of the government agencies named here. I have no doubt that the agencies will eventually bounce back under the right circumstances, but it is disheartening how far agencies such as the EPA, once regarded as models of well run government (at least to a developing country!) have fallen.

  • | |

    Colonialism, Pharmaceutical style

    Byoliveridley

    Legal wrangle puts India’s generic drugs at risk – health – 29 January 2007 – New Scientist

    Tens of thousands of people being treated for AIDS will suffer if Swiss pharmaceutical company Novartis succeeds in changing India’s patent law, the humanitarian agency Medecins Sans Frontieres warned on Monday. Novartis is challenging a specific provision of India’s patent law that, if overturned, would see patents being granted far more widely, heavily restricting the availability of affordable generic medicines, MSF says.

    In 2000, antiretroviral (ARV) treatment cost was estimated at $10,000 per patient annually. But the availability of generic drugs produced mainly in India, allowed costs to plummet to about $70 per patient per year, Mwangi adds.

    You’ve got to love the friendly multinational arguing to make extra billions while people die. But I don’t think any Indian judge will overthrow Indian patent law. And there is a national interest  exemption built into most patent statutes, per the TRIPs agreements.

  • |

    Pet Poisonings – A chemistry detective story

    Byoliveridley

    Melamine in pet food may not be accidental – USATODAY.com

    A nitrogen-rich chemical used to make plastic and sometimes as a fertilizer may have been deliberately added to an ingredient in pet food that has sickened and killed cats and dogs across the country, public and private officials say. A leading theory is that it was added to fake higher protein levels.

    Melamine has been found in wheat gluten, rice protein concentrate and, in South Africa, corn gluten, all imported from China, and all meant for use in pet food, the Food and Drug Administration confirmed Thursday.

    “It adds to the theory when you see other products that are labeled as protein supplements, in this case rice protein, and in South Africa corn gluten and in the previous case wheat gluten,” said Stephen Sundlof, FDA chief veterinarian. “That melamine was found in all three of those, it would certainly lend credibility to the theory that this was intentional.”

    Interesting, apparently, melamine was added to increase the nitrogen content of the food so it would show up as protein in the most common protein test, which only looks for nitrogen. When I am not working, I guess I will look up the test details.

    I wonder if this is only the tip of the iceberg? What other techniques do food manufacturers use to fake it? Growing up, food adulteraion was a serious problem in India, and still continues to be an issue in the third world.

    More on this story to come, I am sure.

    One more thing that needs to be said is that the FDA has been very reactive, as opposed to proactive. This is partly because the FDA does not issue recalls, it first “strongly suggests” that the company involved recall whatver product it is that may be having issues. Only if this issue is not addressed can the FDA start seizure proceedings, which could take months. The FDa regulates and monitors on a company level, not at a product level.

    For example, when Japan had one sample of U.S beef test positive for mad cow disease, that was the end of beef imports from the U.S. This is an extreme case because you’re dealing with an infectious disease, but the point is that when you are finding huge levels of pesticide in food from a country, the first thing you need to do is stop everything, troubleshoot, then turn things back on again. Yes, this gets expensive, but so does 1000s of sick pets. The difference is, who pays. In the U.S, it’s always the consumer!

One Comment

  1. But what has happened to Drexelina and Sundae?

    Just been blogging about this. Is there something they aren’t tell us?

Comments are closed.